MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Monday, September 23, 2019

1:45pm-3:15pm
Acquired hepatocerebral degeneration treated with calcium disodium edetate chelation

Z. Voysey, L. Azzopardi, B. Fiddes, S. Bradberry (Romford, United Kingdom)

Rare Genetic and Metabolic Diseases  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Acute chorea secondary to cephalosporin

BED. Ines, BRA. Zeineb, MAN. Malek, ZAO. Jamel, MRI. Ridha (Tunis, Tunisia)

Choreas (Non-Huntington’s Disease)  ·  Les Muses, Level 3
1:45pm-3:15pm
Acute hemichorea in patient of uncontrolled type 2 diabetes mellitus; a case report with characteristic imaging

M. Salem, A. Helmy, E. Abdeldayem, A. Shalash (Cairo, Egypt)

Choreas (Non-Huntington’s Disease)  ·  Les Muses, Level 3
1:45pm-3:15pm
Acute hypertensive crisis with myoclonic movements induced by withdrawal of intrathecal combined clonidine and morphine administration

A. Saryyeva, J. Krauss, L. Cassini Ascencao (Hannover, Germany)

Myoclonus  ·  Les Muses, Level 3
1:45pm-3:15pm
Acute, contact-dependent behavioral changes in Parkinson disease (PD) patients during monopolar contact review of subthalamic deep brain stimulation (DBS) using directional leads

CHR. Vander Linden, C. Bogaert, D. Colle, H. Colle (Ghent, Belgium)

Psychiatric Manifestations  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Addition of Opicapone to Safinamide in Parkinson’s Disease patients

M. Russo, C. Carrarini, F. Dono, M. Di Pietro, M. Rispoli, L. Ferri, M. Onofrj (Chieti, Italy)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Advanced Care Planning in complex Parkinson’s disease

L. Richardson, N. Butt, M. Khwaja, H. Avery, G. Alg, A. Chatterjee (Reading, United Kingdom)

Quality of Life  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Agreement Between the GAITRite® Walkway System and the Wearable Inertial Sensor BTS G-Walk® for Measurement of Gait Parameters

H. Horáková, K. Poláková, E. Růžička, H. Brožová (Prague, Czech Republic)

Other  ·  Agora 2 West, Level 2
1:45pm-3:15pm
Alcohol- Induced Cerebellar Ataxia

B. Zeigelboim, H. Teive, C. Santos Junior, J. Malisky, M. da Rosa, R. Sampaio, M. José (Curitiba, Brazil)

Ataxia  ·  Les Muses, Level 3
1:45pm-3:15pm
Alexander Technique Group Classes Are a Feasible and Promising Intervention for Care Partners of People living with Parkinson’s disease

M. Gross, R. Ravichandra, B. Mello, R. Cohen (Candler, NC, USA)

Caregiver Burden  ·  Les Muses Terrace, Level 3
  • «Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 75
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • #25179 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley